In India, the process of a clinical trial is often lengthy and complex due to the diverse and migratory population groups. As a result, India has long relied on western data, which may not be applicable to the Indian population. The process of real-world evidence (RWE) means that India can gather data from its own ethnic groups and apply it to the betterment of clinical processes.
Real-world evidence (RWE) refers to data collected from sources other than traditional randomized clinical trials (RCTs), such as observational studies, electronic health records, and patient registries. RWE provides insights into how medical products perform in realworld settings, which is useful for evaluating the safety, effectiveness, and cost-effectiveness of healthcare intervention.
RWE differs from traditional clinical trial data in that it is collected in a real-world setting and involves a more diverse and representative population. Clinical trial data is collected in a controlled environment with specific inclusion and exclusion criteria, which may not be representative of the population as a whole.
RWE can help improve patient outcomes and healthcare decision-making in India by providing a more comprehensive understanding of how interventions work in diverse populations and settings. This can inform the development of more targeted and effective interventions, as well as support evidence-based policy decisions.
RWE challenges in India
RWE is a promising tool for healthcare research, but its effectiveness hinges on the quality of the data used. In the Indian context, there are several challenges to using RWE in healthcare, observes Amrit Singh, Co-founder and CRO at Loop Health. "These include incomplete or inaccurate data, limited availability of electronic health records, and variations in healthcare practices across different regions," he says.
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Granules' Visakhapatnam - Unit V facility passes FDA inspection
Granules India's Unit V facility in Visakhapatnam has completed US FDA inspection with zero 483 observations.
Mankind to set up 'Digital Smart Classrooms' in villages
Under the project, Mankind Pharma to equip 220 government schools from Uttar Pradesh, Himachal Pradesh, and Uttarakhand with learning tools and technology.
Indegene acquires medical writing player from Germany
Indegene acquires Trilogy Writing & Consulting GmbH, enhancing medical writing capabilities for life sciences companies.
Medulance bags 25.06 cr series-A VC funding
Latest VC funding to be invested in expanding emergency healthcare in India.
HUMAN TOUCH IN HEALTHCARE
Healthcare must prioritize empathy, not efficiency, for better patient experience, moving from cost center to core strategy, argues author
SMART BANDAGES A REVOLUTION IN WOUND CARE
Wound care is about to get a technological upgrade! See how next-generation intelligent dressings may help to fight infections and assist in the fast healing of wounds
THE EMERGING THREAT OF LUPUS
Explore the prevalence and growth rates of Lupus in India and ways to tackle this emerging healthcare challenge.
INDIA'S NURSES' SHORTAGE: FINDING CURE
The acute scarcity of nurses is burdening India's healthcare system, risking patient care outcomes. Explore the way forward.
New guidelines to address fluid management in hospitalized patients
API and Kenvue India release guidelines for managing oral fluids, electrolytes, and energy in non-diarrheal patients for hospitals in India.
HealthTech hiring stays strong despite funding slowdown - Report
India's HealthTech hiring demonstrates resilience with employment surging by nine percent amidst a funding deceleration.